Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression
Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr, Lobna Ibrahim, Nancy Diazgranados, David A Luckenbaugh, Rodrigo Machado-Vieira, Jacqueline Baumann, Alan G Mallinger, Carlos A Zarate Jr
Abstract
Background: Ketamine rapidly improves depressive symptoms in patients with treatment-resistant major depressive disorder (MDD) who do not respond to multiple standard antidepressants. However, it remains unknown whether ketamine is equally effective in patients with MDD who previously also did not respond to electroconvulsive therapy (ECT).
Methods: This study compared 17 patients with treatment-resistant MDD who previously did not respond to ECT and 23 patients with treatment-resistant MDD who had not previously received ECT. All subjects received a single open-label infusion of ketamine (0.5 mg/kg). Patients were evaluated using the Montgomery-Asberg Depression Rating Scale (MADRS) at baseline (60 min before the infusion), as well as at 40, 80, 120, and 230 min after infusion.
Results: Depressive symptoms were significantly improved in the ECT-resistant group at 230 minutes with a moderate effect size (p < .001, d = 0.50, 95% C.I.: 0.21-0.80). At 230 minutes, the non-ECT exposed group showed significant improvement with a large effect size (p < .001, d=1.00, 95% C.I.: 0.71-1.29).
Conclusion: Ketamine appears to improve depressive symptoms in patients with MDD who had previously not responded to ECT. These preliminary results encourage further investigation with a larger sample size to determine effectiveness compared to other treatment-resistant patients with MDD.
Published by Elsevier Inc.
Figures


Source: PubMed
Upcoming Clinical Trials
-
NCT07935395Not yet recruiting
-
NCT07935252Not yet recruitingAcute and Chronic Postsurgical Pain
-
NCT07870876RecruitingVascular Access | Vascular Access Complication | Vascular Access Devices
-
NCT07936006RecruitingHypoxia | Caffeine | Placebo - Control
-
NCT07936461RecruitingFeasibility of Occupation-Based Immersive Virtual Reality for Upper-Limb Rehabilitation After StrokeStroke | Upper Extremity Paresis
-
NCT07935161Not yet recruitingPreterm Prelabor Rupture of Membranes (PPROM)
-
NCT07934602Not yet recruiting
-
NCT07936110RecruitingYoung Adult | Chronic Ankle Instability, CAI
-
NCT07901374Not yet recruitingKnee Osteoarthritis | Chronic Knee Pain
-
NCT07935278RecruitingMild Traumatic Brain Injury | Concussion (Diagnosis)
-
NCT07934745Not yet recruiting